Antithrombotic Therapy Change Reason

General Details:

Name:
Antithrombotic Therapy Change Reason
Steward:
NHLBI
Definition:
The reason(s) for a change in active antithrombotic pharmacotherapy. Changes can include discontinuation of therapy, change in dose, change in frequency, change in product, or change in route of administration.
Registration Status:
Qualified

Permissible Values:

Data Type:
Value List
Unit of Measure:
Ids:
Value Code Name Code Code System Code Description
Completion of Therapy Completion of Therapy
Failure of therapy due to new or progressive VTE Failure of therapy due to new or progressive VTE
Intolerance of therapy due to bleeding Intolerance of therapy due to bleeding
Intolerance of therapy due to non-bleeding adverse event Intolerance of therapy due to non-bleeding adverse event
Cost Cost
Lack of availability Lack of availability
Dose adjustment based on laboratory monitoring Dose adjustment based on laboratory monitoring
Change in creatinine clearance Change in creatinine clearance
Drug-drug interaction caused by change in concomitant medication(s) Drug-drug interaction caused by change in concomitant medication(s)
Change in weight Change in weight
Change in liver function Change in liver function
Change in goals of care Change in goals of care
Other reason Other reason
Death Death

Designations:

Designation:
Antithrombotic Therapy Change Reason
Tags:
Designation:
Reason for Changing Pharmacotherapy
Tags:
Suggested Question Text

Designations:

Definition:
The reason(s) for a change in active antithrombotic pharmacotherapy. Changes can include discontinuation of therapy, change in dose, change in frequency, change in product, or change in route of administration.
Tags:

Identifiers:

Source:
NLM
Id:
gGur_P2NLK
Version:
Source:
ISTH
Id:
17:6:6:3
Version: